Ningxia Zhongke Biotechnology Co., Ltd

Equities

600165

CNE000000W47

Commodity Chemicals

End-of-day quote Shanghai S.E. 06:00:00 2024-07-21 pm EDT 5-day change 1st Jan Change
2.08 CNY -5.02% Intraday chart for Ningxia Zhongke Biotechnology Co., Ltd -0.95% -38.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ningxia Zhongke Biotechnology Co., Ltd(SHSE:600165) dropped from Shanghai Stock Exchange Composite Index CI
Ningxia Zhongke Biotechnology Co., Ltd(SHSE:600165) dropped from Shanghai Stock Exchange A Share Index CI
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chinese Securities Regulator Warns Zhongke Biotechnology Over Late Disclosure of Unit's Suspension MT
China stocks roughly flat as sentiment remains subdued; HK shares up RE
China stocks jump on strong PMI data RE
Court Orders Freezing of Zhongke Biotechnology's Bank Accounts Worth 2.6 Million Yuan MT
Benchmark Mortgage Rate Cuts Boost Chinese Stocks; Zhongke Biotechnology Jumps 5% MT
Zhongke Biotechnology's Chairman Resigns MT
Ningxia Zhongke Biotechnology Co., Ltd(XSSC:600165) dropped from S&P Global BMI Index CI
Zhongke Biotechnology Terminates Partnership With New Materials Firm MT
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Ningxia Zhongke Biotechnology Co., Ltd(XSSC:600165) added to S&P Global BMI Index CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shouguang Jintou New Material Technology Co., Ltd. cancelled the acquisition of an unknown stake in Ningxia Zhongke Biotechnology Co., Ltd. from Shanghai Zhongneng Enterprise Development Co., Ltd. CI
Zhongke Biotechnology Sees Loss Widening for 2022 MT
Zhongke Biotechnology Ends Agreement With Guiyuan Biotechnology MT
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shouguang Jintou New Material Technology Co., Ltd. signed a Share Transfer Intention Agreement to acquire an unknown stake in Ningxia Zhongke Biotechnology Co., Ltd. from Shanghai Zhongneng Enterprise Development Co., Ltd. CI
Ningxia Xinri Hengli Steel Wire Rope Co., Ltd entered into an agreement to acquire 10% stake in Ningxia Hengli Biological New Material Co., Ltd. from Shizuishan Zhengxingcheng New Material Technology Partnership Enterprise (Limited Partnership) for CNY 106 million. CI
Ningxia Xinri Hengli Steel Wire Rope Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Ningxia Xinri Hengli Steel Wire Rope Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chart Ningxia Zhongke Biotechnology Co., Ltd
More charts
Ningxia Zhongke Biotechnology Co Ltd, formerly NINGXIA XINRI HENGLI STEEL WIRE CO. LTD., is a China-based company mainly engaged in the production and sales of coal-based activated carbon. The Company's main businesses include chemical raw materials and chemical products manufacturing. The Company's products mainly include water purification activated carbon, air purification carbon, solvent recovery carbon, catalyst carrier carbon, chemical protective carbon and mercury removal carbon. The Company is also engaged in the large-scale production of lauric acid. The Company mainly operates its businesses in the domestic market and overseas markets.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600165 Stock
  4. News Ningxia Zhongke Biotechnology Co., Ltd
  5. Benchmark Mortgage Rate Cuts Boost Chinese Stocks; Zhongke Biotechnology Jumps 5%